Stable anti-OSMR antibody formulation

A stable formulation comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.1-7.1,

• wherein the formulation comprises 10-150 mM arginine, 10-20 mM histidine, or 5-75 mM phosphate,
• wherein the anti-OSMR antibody has a pI ranging from 6.5-8.0 and is present in the formulation at a concentration ranging from 100-250 mg/ml, and
• wherein at least 90% of the anti-OSMR antibody exists as monomer in the formulation upon storage at 40° C. for two weeks;
• and
• wherein the anti-OSMR antibody comprises (i) a heavy chain having the amino acid sequence set forth in SEQ ID NO:
• 1;
• and a light chain having the amino acid sequence set forth in SEQ ID NO:
• 2;
• or (ii) a heavy chain variable domain having the amino acid sequence set forth in SEQ ID NO:
• 3;
• and a light chain variable domain having the amino acid sequence set forth in SEQ ID NO:
• 4,
• wherein the formulation is aqueous.